How Dotmatics is Helping Science Teams Work Remotely
Dotmatics has facilitated remote and hybrid scientific work during and beyond the 2020 pandemic by providing cloud-based real-time data access, experiment planning tools, and lab data automation that enable scientists to collaborate, plan, and analyze experiments efficiently from any location while maintaining lab safety and capacity.
2020: The Year of Remote Working – Even for Lab Scientists
In 2020, many organizations had to make significant changes to their business practices due to the pandemic. Initially, this involved quickly figuring out how to work remotely. Soon after, companies adjusted to a hybrid model, allowing scientists to return to labs for essential research while maintaining remote interaction and social distancing outside the lab.
As companies consider long-term sustainable plans, some of these new ways of working and connecting are likely to remain. Dotmatics has contributed to helping customers succeed with these new work practices:
-
Cloud Systems for Real-Time Access: Dotmatics' cloud systems provide real-time access to all scientific project data, along with powerful analytics and visualization tools, for all team members regardless of location. Previously used for collaboration with partners and CROs, these systems have become invaluable for internal teams working remotely from each other when not in the lab.
-
Cloud-Based Experiment Planning: Scientists can plan experiments and enter data easily whether they are in the lab, office, or at home. This flexibility allows them to optimize lab time for conducting experiments and then vacate the lab for write-up and planning, helping maintain distancing and free up lab capacity for others.
-
Lab Data Automation: Dotmatics' lab data automation solution enables data to be captured from instruments, processed, visualized, or sent for analysis in a fully automated way. This process does not require scientists to be present in the lab for data collection.
Dotmatics has also supported organizations like Debiopharm in ensuring their data and transactional systems remain accessible to distributed workforces.
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Transitioning to a Modern ELN
The article discusses how modern Electronic Laboratory Notebooks (ELNs), exemplified by Dotmatics ELN, have evolved beyond simple digitization to support cross-disciplinary R&D teams in pharma and materials science by integrating diverse data, streamlining workflows, enabling advanced searchable and shareable data access, and facilitating faster, collaborative innovation throughout the make-test-decide cycle.
A Scientific R&D Platform for Startup Biotech to Large Biopharma
Independent Informatics Consultant Bob Coner leverages Dotmatics' flexible, scalable, and user-friendly scientific R&D platform to help clients ranging from biotech startups to large biopharma companies automate lab data capture, integrate legacy systems, manage diverse research workflows—including electronic lab notebooks, compound registration, inventory, assay data management, and secure cloud storage—ultimately enhancing research decision-making and protecting intellectual property.
Dotmatics Appoints Mike McKee as President and CEO
Dotmatics Ltd has appointed experienced technology CEO Mike McKee as its new President to accelerate the company's growth, scale its global team, double R&D investments, and lead integration efforts within Insightful Science's portfolio, succeeding founder Stephen Gallagher who will focus on strategic growth initiatives.
Data Management, Collaboration, and Workflow Optimisation: The Three Keys to Small Molecule Discovery Success
The article emphasizes that despite biologics' prominence, small molecule drug discovery is experiencing a renaissance driven by advances in screening, target exploration, and AI, but overcoming challenges like rising costs, data management, fragmented workflows, and CRO reliance requires success in three key areas: next-generation data management, enhanced cross-disciplinary research collaboration, and workflow optimization.
Dotmatics Case Studies
Dotmatics showcases diverse case studies where leading pharmaceutical, chemical, and biotech companies leverage its electronic lab notebook (ELN), data discovery, and analysis platforms to transform scientific data management, streamline R&D workflows, enhance drug discovery, and drive collaborative innovation across various research domains.